2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) / Lyon, A. R.; Lopez-Fernande, T.; Couch, L. S.; Asteggiano, R.; Aznar, M. C.; Bergler-Klei, J.; Boriani, G.; Cardinale, D.; Cordoba, R.; Cosyns, B.; Cutter, D. J.; De Azambuja, E.; De Boer, R. A.; Dent, S. F.; Farmakis, D.; Gevaert, S. A.; Gorog, D. A.; Herrmann, J.; Lenihan, D.; Moslehi, J.; Moura, B.; Salinger, S. S.; Stephens, R.; Suter, T. M.; Szmit, S.; Tamargo, J.; Thavendiranathan, P.; Tocchetti, C. G.; Van Der Meer, P.; Van Der Pal, H. J. H.; Metra, M.. - In: EUROPEAN HEART JOURNAL. - ISSN 0195-668X. - 43:41(2022), pp. 4229-4361. [10.1093/eurheartj/ehac244]

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

Metra M.
Membro del Collaboration Group
2022-01-01

2022
Amyloid light-chain cardiac amyloidosis
Androgen deprivation therapy
Anthracycline
Arrhythmias
Atrial fibrillation
Biomarkers
Cancer
Cancer survivors
Carcinoid syndrome
Cardiac magnetic resonance
Cardiac tumour
Cardio-oncology
Cardiotoxicity
Chemotherapy
Coronary artery disease
Echocardiography
Fluoropyrimidine
Guidelines
Haematopoietic stem cell transplantation
Heart failure
Hormone therapy
Hypertension
Immunotherapy
Ischaemic heart disease
Myocarditis
Pericardial disease
Pericardial disease
Proteasome inhibitors
Pulmonary hypertension
QTc prolongation
Radiotherapy
Risk stratification
Strain
Thrombosis
Trastuzumab
Valvular heart disease
Vascular endothelial growth factor inhibitors (VEGFi)
Venous thromboembolism
File in questo prodotto:
File Dimensione Formato  
ehac244.pdf

accesso aperto

Tipologia: PDF editoriale (versione pubblicata dall'editore)
Licenza: Licenza OA dell'editore
Dimensione 10.63 MB
Formato Adobe PDF
10.63 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/201582
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2390
  • ???jsp.display-item.citation.isi??? ND
social impact